📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension. (2021)

First Author: Alves-Lopes R

Attributed to: Capacity Building in Redox Biology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.121.17041

PubMed Identifier: 34304582

Publication URI: http://europepmc.org/abstract/MED/34304582

Type: Journal Article/Review

Volume: 78

Parent Publication: Hypertension (Dallas, Tex. : 1979)

Issue: 3

ISSN: 0194-911X